尼莫地平联合复方丹参右旋糖酐治疗脑梗死的临床研究

Clinical Study of Nimodipine Combined With Compound Danshen Dextran in Treatment of Cerebral Infarction

目的 探究尼莫地平联合复方丹参右旋糖酐治疗脑梗死的临床效果。方法 选取我院2013年9月~2015年9月收治的75例脑梗死患者,经随机抽签的方式,分成观察组和对照组,分别为38例、37例。两组均采用复方丹参右旋糖酐治疗,观察组在此之上联合尼莫地平治疗,对比两组临床疗效。结果 观察组的治疗总有效率为94.74%,高于对照组的治疗总有效率75.68%,P〈0.05。治疗前、后,两组神经功能缺损评分比较,P〈0.05。结论 脑梗死,经尼莫地平联合复方丹参右旋糖酐治疗,临床疗效显著,且能改善患者的神经功能缺损症状。

Objective Explore the nim pass joint compound salvia miltiorrhiza dextran clinical effect for the treatment of cerebral infarctionl Methods 75 cases of cerebral infarction patients were selected from September 2013 to September 2015, the random lottery, divided into observation group and control group, 38 cases, 37 cases respectively. Both groups of compound salvia miltiorrhiza dextran treatment, observation group on top of this joint nim treatment, compared two groups of clinical curative effect. Results Observation group total effective rate 94.74%, significantly higher than the control group total effective rate 75.68%, P〈0.05. Before and after treatment, compared two groups of neural function defect scale, P〈0：05. Conclusion Cerebral infarction by nim through joint compound salvia miltiorrhiza dextran treatment, the clinical curative effect is distinct, and can improve the symptoms of the patient＇s neurologic deficits.